CDI Research Day 2026 Features Emerging Talents Who Tackle Infections, Cancer, and Behaviors

Researchers at CDI Research Day 2026.

Painstaking infectious disease mechanisms, advanced cancer therapies, patient experiences and mental health, and the foundational understanding of pathogenesis of all types were all on display at the third annual CDI Research Day on Nov. 5.

The main auditorium was near capacity throughout the full day of events at the Hackensack Meridian Center for Discovery and Innovation (CDI). The proceedings included nine oral presentations, seven “flash talks” of just a few minutes apiece, 25 posters spread out over two sessions in the lobby, a keynote by a top fungal researcher, a series of awards, and a reception at the end.

“CDI Research Day is a great way to feature the exceptional work of our earliest stage investigators,” said David Perlin, Ph.D., chief scientific officer and executive vice president, of the CDI.

The afternoon culminated in a keynote address by Michail Lionakis, M.D., Sc.D., chief of the Laboratory of Clinical Immunology and Microbiology, and chief of the Fungal Pathogenesis Section at the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health. Introduced by Jigar Desai, Ph.D., whom he mentored years ago, Lionakis delivered an inspired presentation titled, "Translating Core Human Immunology into Antifungal Immunotherapy," bridging the gap between fundamental bench science and critical patient interventions in understanding and combating Candida and Aspergillus infections.

Judged by a panel of CDI faculty, the 2026 awards for the Day included:

Oral Presentations

  • Geselle Cancino-Prado, presented her work on “Antifungal Activity of Tavaborole and Novel Benzoxaboroles Against Candida auris and other Candida spp.” (1st Place)
  • Evangelos Liapis, talked about his research entitled “Development of Clinically Relevant Three-Dimensional Models of Pediatric and Adult Brain Tumors.” (2nd Place)
  • Tabinda Sidrat, delivered “Antibody-drug-conjugates (ADCs) with lineage-specific anti-tumor activity against human adenoid cystic carcinoma (ACC).” (3rd Place)

Poster Presentations

  • Raju Shivarathri’s poster, “Complement C5AR1 signaling integrates microbial cues, myeloid inflammation, and cancer-cell survival in colorectal cancer” was the winner in its category. (1st Place)
  • Dhanya Dhanyalayam, produced “Macrophage Adrenergic Signaling Drives Sex Differences in Mtb Clearance.” (2nd Place)
  • Syeda Maryam Azeem, delivered her poster “Lipid Droplet Proteome of Mycobacterium tuberculosis and Its role in Drug-Tolerant TB Persistence.” (3rd Place)

CDI Research Day was conceived in 2024 to provide a platform for postdocs, research associates, and other laboratory staff to present their research findings and to update colleagues on all the latest work across the CDI various fields of expertise, potentially opening up new avenues of collaboration - and moments of inspiration.

The CDI organizers of the 2026 event included CDI scientists Erika Shor, Ph.D., Alvin Makohon-Moore, Ph.D., and Claire Carter, Ph.D. As emphasized during the event’s opening proceedings, Research Day is fundamentally about trainees and scientists still toward the beginnings of their careers, who most often work behind the scenes alongside renowned, veteran principal investigators at the CDI.